A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone
CompletedOBSERVATIONAL
Enrollment
20
Participants
Timeline
Start Date
June 30, 2012
Primary Completion Date
November 30, 2014
Conditions
Prostate Cancer (Adenocarcinoma)
Trial Locations (2)
V5Z 4E6
BC Cancer Agency, Vancouver
M5G2M9
Princess Margaret Cancer Centre, Toronto
All Listed Sponsors
lead
University Health Network, Toronto
OTHER
NCT01857908 - A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone | Biotech Hunter | Biotech Hunter